Cite Filings / MDGL / 0001628280-26-069145

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

MADRIGAL PHARMACEUTICALS, INC. Filed 2026-11-03 Acc 0001628280-26-069145

Documents 1

10-Q Quarterly Report , mdgl-20260930.htm

Around this filing

2026-11-06 144 Sale of Securities
2026-11-06 4 General Counsel sold 1,077 shares at $400.00 ($430,800)
2026-11-06 4 Director bought 91,806 shares at an average $381.49 ($35,023,032)
2026-11-06 SCHEDULE 13D/A Beneficial Ownership Report
2026-11-03 10-Q Quarterly Report
2026-11-03 8-K Results of operations
2026-07-30 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading mdgl-20260930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…